Indonesia Cyclotron PET-CT Business Model Rev IDR (2) - Nidya
Indonesia Cyclotron PET-CT Business Model Rev IDR (2) - Nidya
Indonesia Cyclotron PET-CT Business Model Rev IDR (2) - Nidya
Year 1 2 3 4 5 6 7 8 9 10
Scan/Examination Fees - - 1,900,800 2,851,200 2,851,200 3,564,000 3,564,000 3,564,000 3,564,000 3,564,000
PER MONTH - - 158,400.00 237,600.00 237,600.00 297,000.00 297,000.00 297,000.00 297,000.00 297,000.00
Operating Cost
Number of staff 0 0 3 3 3 3 3 3 3 3
Salaries (average per staff monthly) 4,500 - - 162,000 162,000 162,000 162,000 162,000 162,000 162,000 162,000
NM (commission per scan) 15% 285,120 427,680 427,680 534,600 534,600 534,600 534,600 534,600
Maintenance (Service Contract) 70,000 73,500 77,175 81,034 85,085 89,340 93,807 98,497
FDG Supplies per Exam (USD) 300 300 300 300 300 300 300 300
FDG Supplies (USD) 633,600 950,400 950,400 1,188,000 1,188,000 1,188,000 1,188,000 1,188,000
Buffer / Utilities (% of revenue) 5% 95,040 142,560 142,560 178,200 178,200 178,200 178,200 178,200
Consumables $ per Exam 28 28 29 31 32 34 36 38 39
59,136 93,139 97,796 128,357 134,775 141,514 148,590 156,019
Total Operating Costs (excluding consultancy) - - 1,304,896 1,849,279 1,857,611 2,272,191 2,282,661 2,293,654 2,305,196 2,317,316
Earning before depreciation, interest and tax (EBITDA) - - 595,904 1,001,921 993,589 1,291,809 1,281,339 1,270,346 1,258,804 1,246,684
EBITDA Margin (%) #DIV/0! #DIV/0! 31% 35% 35% 36% 36% 36% 35% 35%
Operating Model
4,000,000
Interest (financing) - - - - - - - - - - 3,500,000
Depreciation 140,000 140,000 140,000 140,000 140,000 140,000 140,000 140,000 140,000 140,000 3,000,000
Profit before tax (140,000) (140,000) 455,904 861,921 853,589 1,151,809 1,141,339 1,130,346 1,118,804 1,106,684
2,500,000
Tax - - 113,976 215,480 213,397 287,952 285,335 282,587 279,701 276,671
2,000,000
Net Profit (140,000) (140,000) 341,928 646,441 640,192 863,857 856,004 847,760 839,103 830,013
1,500,000
1,000,000
500,000
Cashflow Analysis 0
Capital Expenditure 1,400,000 1 2 3 4 5 6 7 8 9 10
Tax 0 113,976 215,480 213,397 287,952 285,335 282,587 279,701 276,671
EBITDA 0 595,904 1,001,921 993,589 1,291,809 1,281,339 1,270,346 1,258,804 1,246,684 Repayment + Interest (financing) Revenue
Debt Funding 0 0 0 0 0 0 0 0 0 Cost Earnings
Equity Funding 1,400,000 0 0 0 0 0 0 0 0
Repayment + Interest (financing) 0 0 0 0 0 0 0 0 0
Cashflow carried forward - 481,928 786,441 780,192 1,003,857 996,004 987,760 979,103 970,013
Returns Analysis
Project Returns (1,400,000) 481,928 786,441 780,192 1,003,857 996,004 987,760 979,103 970,013
Cummulative (1,400,000) (918,072) (131,631) 648,560 1,652,417 2,648,421 3,636,181 4,615,284 5,585,296
This business feasbility tool has been developed for simulation and illustrative purposes only, and you should not rely upon it as an indicator of actual revenues and expenses.
Actual revenues and expenses will vary depending on your specific operating costs, numbers and types of procedures performed, and reimbursement amounts.
Consolidated
FCF for Cyclotron (4,755,686) (55,686) 1,001,529 3,027,520 3,010,360 3,801,873 3,726,815 3,703,975 3,493,382 3,465,745
FCF Consolidated (4,755,686) (1,455,686) 1,483,457 3,813,960 3,790,551 4,805,729 4,722,820 4,691,735 4,472,484 4,435,758
IRR 39%
MAN POWER PLANNING (Assuming 2 Cyclotron sites)
one SITE
Engineer & Services 1 8,000,000 8,000,000
Marketing 1 -
Med Physics and Chemist 4 8,000,000 32,000,000
Operational Admin 3 4,500,000 13,500,000
Site Leader 1 13,000,000 13,000,000